Patrik Olof DahlÚn is a Finnish businessperson who has been at the head of 16 different companies.
He holds the position of Chairman at Visiopharm An and Chairman at Advalight ApS.
He is also on the board of ViroGates A, Immudex A, SSI Diagnostica A (former Co-Chief Executive Officer) and Byggvarulistan i Sverige AB.
In the past Dr. DahlÚn occupied the position of Chairman for Anapa Biotech A, Chairman of Denator AB, Chairman at Moleculink AB, Chief Executive Officer of NTG Nordic Transport Group A, Chief Executive Officer for Chempaq A, Chief Executive Officer for Immunovia AB, Senior Vice President of PerkinElmer, Inc. (United States) Chief Executive Officer & Executive Director at Immunodiagnostic Systems Holdings Ltd. President for PerkinElmer Life Sciences, Inc. and Head-Diagnostics Systems at Wallac Oy (which are all subsidiaries of PerkinElmer, Inc. (United States)), Chairman at Sophion Bioscience A, Chairman at Proxeon Biosystems ApS, President & Chief Executive Officer for Dako Denmark ApS, Chief Executive Officer of BioImage A, President & Chief Executive Officer for Dako Corp. and General Manager of EG&G Reticon.
Dr. DahlÚn received a doctorate from the University of Turku and a graduate degree from ┼bo Akademi University.